Who
Martin P. Sutter
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Bioventus; Director, Abiomed; Director and 10% owner, Ats Medical; Director and 10% owner, Bioform Medical; Director, La Jolla Pharmaceutical Co; Director, Lifecell.
In numbers
- Trades disclosed
- 342
- Buys
- 11
- Sells
- 34
- Bought
- $35.7M
- Sold
- $50.6M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 25 Apr 2006
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,282 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —26,493 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,400 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —30,400 at $0.00 | filing |
| 7 Jun 2023filed 13 Jun 2023 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,400 at $0.00 | filing |
| 6 Jun 2023filed 13 Jun 2023 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —16,648 at $0.00 | filing |
| 6 Jun 2023filed 13 Jun 2023 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —16,648 at $0.00 | filing |
| 22 Dec 2022filed 27 Dec 2022 | Abiomed | SEC FORM 4 Code D | —123,370 | filing |
| 16 Nov 2022filed 17 Nov 2022 | Abiomed | SEC FORM 4 Sold | $696K1,859 at $374.66 | filing |
| 16 Nov 2022filed 17 Nov 2022 | Abiomed | SEC FORM 4 Sold | $53K141 at $375.56 | filing |
| 15 Nov 2022filed 17 Nov 2022 | Abiomed | SEC FORM 4 Sold | $424K1,133 at $374.18 | filing |
| 15 Nov 2022filed 17 Nov 2022 | Abiomed | SEC FORM 4 Sold | $325K867 at $374.92 | filing |
News
No headline names them, or the companies they trade most, lately.